ADIPOQ and metabolic syndrome: Consistently with published works [19], we found that three months after the onset of high-fat regimen, mice developed major abnormalities resembling to human metabolic syndrome such as glucose intolerance, insulin resistance, elevated glucose, insulin and leptin circulating levels and reduced adiponectin blood concentration.